Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 4, 1996, Pages 409-432

  Spencer, Thomas ^a,b   Biederman, Joseph ^a,b   Wilens, Timothy ^a,b   Harding, Margaret ^a   O'Donneel, Deborah ^a   Griffin, Susan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Attention deficit hyperactivity disorder; Comorbidity; Psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGE; ATTENTION DEFICIT DISORDER; CHILD; ETHNIC GROUP; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; REVIEW; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 0030113274     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199604000-00008     Document Type: Article

References (202)

1. Abikoff H, Gittelman R (1985a), Hyperactive children treated with stimulants. Arch Gen Psychiatry 42:953-961
2. Abikoff H, Gittelman R (1985b), The normalizing effects of methylphenidate on the classroom behavior of ADDH children. J Abnorm Child Psychol 13:33-44
3. Adler L, Resnick S, Kunz M, Devinsky O (1995), Open-label trial of venlafaxine in attention deficit disorder. Presented at the New Clinical Drug Evaluation Unit Program, Orlando, FL
4. Alexandris A, Lundell FW (1968), Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children. Can Med Assoc J 98:92-96
5. Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN (1991), Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J Am Acad Child Adolesc Psychiatry 30:246-256
6. Amery B, Minichiello M, Brown G (1984), Aggression in hyperactive boys: Response to d-amphetamine. J Am Acad Child Psychiatry 23:291-294
7. Barkley RA (1977), A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 18:137-165
8. Barkley RA (1988), The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc Psychiatry 27:336-341
9. Barkley RA (1991), The ecological validity of laboratory and analogue assessment methods of ADHD symptoms. J Abnorm Child Psychol 19:149-178
10. Barkley RA, Cunningham C (1979), The effects of methylphenidate on the mother-child interactions of hyperactive children. Arch Gen Psychiatry 36:201-208
11. Barkley RA, Karlsson J, Strzelecki E, Murphy JV (1984), Effects of age and Ritalin dosage on mother-child interactions of hyperactive children. J Consult Clin Psychol 52:750-758
12. Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1989), The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry 28:873-881
13. Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M (1991), Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 30:762-767
14. Barrickman L, Perry P, Allen A et al. (1995), Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:649-657
15. Befera M, Barkley RA (1985), Hyperactive and normal girls and boys: mother-child interactions, parent psychiatric status, and child psychopathology. J Child Psychol Psychiatry 26:439-452
16. Bergman A, Winters L, Cornblatt B (1991), Methylphenidate: effects on sustained attention. In: Ritalin: Theory and Patient Management, Greenhill L, Osman B, eds. New York: Mary Ann Liebert, pp 223-231
17. Biederman J, Baldessarini R, Goldblatt A, Lapey K, Doyle A, Hesslein P (1993a), A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry 32:805-813
18. Biederman J, Baldessarini R, Wright V, Knee D, Harmatz J (1989a), A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy. J Am Acad Child Adolesc Psychiatry 28:777-784
19. Biederman J, Baldessarini R, Wright V, Knee D, Harmatz J, Goldblatt A (1989b), A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903-911
20. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S (1993b), A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: III. Lack of impact of comorbidity and family history factors on clinical response. J Am Acad Child Adolesc Psychiatry 32:199-204
21. Biederman J, Faraone SV, Keenan K et al. (1992), Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738
22. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT (1990), Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 29:526-533
23. Biederman J, Gastfriend DR, Jellinek MS (1986), Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 6:359-363
24. Biederman J, Milberger S, Faraone S et al. (1994), Family environmental risk factors for attention deficit hyperactivity disorder: a test of Rutter's indicators of adversity. In: Scientific Proceeding of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York
25. Biederman J, Newcorn J, Sprich S (1991), Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577
26. Biederman J, Thisted R, Greenhill L, Ryan N (1995a), Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year-old children. J Clin Psychiatry 56:87-93
27. Biederman J, Wilens T, Mick E, Milberger S, Faraone S, Spencer T (1995b), Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder. Am J Psychiatry 152:1652-1658
28. Birmaher B, Quintana H, Greenhill L (1988), Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry 27:248-251
29. Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J (1990), Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Res 33:83-94
30. Brown RT, Sexson SB (1988), A controlled trial of methylphenidate in black adolescents. Clin Pediatr (Phila) 27:74-81
31. Brown TE, Gammon GD (1992), ADHD-associated difficulties falling asleep and awakening: clonidine and methylphenidate treatments. Presented at the American Academy of Child and Adolescent Psychiatry, Washington, DC
32. Caine E, Ludlow C, Polinsky R, Ebert M (1984), Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol. J Am Acad Child Psychiatry 23:147-152
33. Campbell M, Green WH, Deutsch SI (1985), Child and Adolescent Psychopharmacology. Beverly Hills, CA: Sage Publications
34. Casat CD, Pleasants DZ, Schroeder DH, Parler DW (1989), Bupropion in children with attention deficit disorder. Psychopharmacol Bull 25:198-201
35. Casat CD, Pleasants DZ, Van Wyck Fleet J (1987), A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacol Bull 23:120-122
36. Chappell P, Scahill L, Schultz R, Riddle M, Leckman J (1994), Guanfacine treatment of children with ADHD and tics: preliminary clinical experience (abstract). In: Proceedings of the NCDEU 34th Annual Meeting, p 29
37. Comings DE, Comings BG (1984), Tourette's syndrome and attention deficit disorder with hyperactivity: are they genetically related? J Am Acad Child Psychiatry 23:138-146
38. Comings DE, Comings BG (1988), Tourette's syndrome and attention deficit disorder. In: Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment, Cohen DJ, Bruun RD, Leckman JF, eds. New York: Wiley, pp 119-136
39. Conners CK (1975), Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. Int J Ment Health 4:61-74
40. Conners C, Casat C, Gualtieri C et al. (in press), Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry
41. Coons HW, Klorman R, Borgstedt AD (1987), Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing. J Am Acad Child Adolesc Psychiatry 26:368-374
42. Cox W (1982), An indication for the use of imipramine in attention deficit disorder. Am J Psychiatry 139:1059-1060
43. Cunningham C, Siegel L, Offord D (1991), A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems. J Child Psychol Psychiatry 32:439-452
44. Cytryn L, Gilbert A, Eisenberg E (1960), The effectiveness of tranquilizing drugs plus supportive psychotherapy in treating behavior disorders of children: a double-blind study of eighty outpatients. Am J Orthopsychiatry 30:113-129
45. Demb H (1991), Use of Ritalin in the treatment of children with mental retardation. In: Ritalin: Theory and Patient Management, Greenhill L, Osman B, eds. New York: Mary Ann Liebert, pp 155-170
46. Denckla MB, Bemporad JR, MacKay MC (1976), Tics following methylphenidate administration: a report of 20 cases. JAMA 235:1349-1351
47. Deutsch CK, Matthysse S, Swanson JM, Farkas LG (1990), Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry 29:189-194
48. Dillon DC, Salzman IJ, Schulsinger DA (1985), The use of imipramine in Tourette's syndrome and attention deficit disorder: case report. J Clin Psychiatry 46:348-349
49. Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL (1989), Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Arch Gen Psychiatry 46:205-212
50. Donnelly M, Zametkin AJ, Rapoport JE et al. (1986), Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response. Clin Pharmacol Ther 39:72-81
51. Douglas V, Barr R, Amin K, O'Neill M, Britton B (1988), Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. J Child Psychol Psychiatry 29:453-475
52. Douglas V, Barr R, Desilets J, Sherman E (1995), Do high doses of stimulants impair flexible thinking in ADHD? J Am Acad Child Adolesc Psychiatry 34:877-885
53. DuPaul G, Barkley R, McMurray M (1994), Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 33:894-903
54. Elia J, Borcherding BG, Rapoport JE, Keysor CS (1991), Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 36:141-155
55. Erenberg G (1982), Stimulant medication in Tourette's syndrome (letter). JAMA 248:1062
56. Erenberg G, Cruse RP, Rothner AD (1985), Gilles de la Tourette's syndrome: effects of stimulant drugs. Neurology 35:1346-1348
57. Evans SW, Pelham WE (1991), Psychostimulant effects on academic and behavioral measures for ADHD junior high school students in a lecture format classroom. J Abnorm Child Psychol 19:537-552
58. Famularo R, Fenton T (1987), The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: a preliminary report. J Clin Psychiatry 48:112-114
59. Faraone S, Biederman J (1994), Is attention deficit hyperactivity disorder familial? Harv Rev Psychiatry 1:271-287
60. Faraone S, Biederman J, Chen WJ et al. (1992), Segregation analysis of attention deficit hyperactivity disorder: evidence for single gene transmission. Psychiatry Genet 2:257-275
61. Faraone SV, Biederman J, Krifcher Lehman B et al. (1993), Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol 102:616-623
62. Firestone P, Davey J, Goodman JT, Peters S (1978), The effects of caffeine and methylphenidate on hyperactive children. J Am Acad Child Psychiatry 17:445-456
63. Gadow K, Nolan E, Sverd J (1992), Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry 31:462-471
64. Gadow K, Sverd J, Sprafkin J, Nolan E, Ezor S (1995), Efficacy of methylphenidate for ADHD in children with tic disorder. Arch Gen Psychiatry 52:444-455
65. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L (1990), Methylphenidate in agressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 29:710-718
66. Gammon GD, Brown TE (1993), Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 3:1-10
67. Garfinkel BD, Webster CD, Sloman L (1975), Methylphenidate and caffeine in the treatment of children with minimal brain dysfunction. Am J Psychiatry 132:723-728
68. Garfinkel BD, Webster CD, Sloman L (1981), Responses to methylphenidate and varied doses of caffeine in children with attention deficit disorder. Am J Psychiatry 26:395-401
69. Garfinkel BD, Wender PH, Sloman L, O'Neill I (1983), Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Psychiatry 22:343-348
70. Gastfriend DR, Biederman J, Jellinek MS (1985), Desipramine in the treatment of attention deficit disorder in adolescents. Psychopharmacol Bull 21:144-145
71. Gittelman R (1980), Childhood disorders. In: Drug Treatment of Adult and Child Psychiatric Disorders, Klein D, Quitkin F, Rifkin A, Gittelman R, eds. Baltimore: Williams & Wilkins, pp 576-756
72. Gittelman R, Mannuzza S (1988), Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 45:1131-1134
73. Gittelman R, Mannuzza S, Shenker R, Bonagura N (1985), Hyperactive boys almost grown up: I. Psychiatric status. Arch Gen Psychiatry 42:937-947
74. Gittelman-Klein R (1974), Pilot clinical trial of imipramine in hyperkinetic children. In: Clinical Use of Stimulant Drugs in Children, Conners C, ed. The Hague: Excerpta Medica, pp 192-201
75. Gittelman-Klein R (1987), Pharmacotherapy of childhood hyperactivity: an update. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 1215-1224
76. Gittelman-Klein R, Klein DF, Katz S, Saraf K, Pollack E (1976), Comparative effects of methylphenidate and thioridazine in hyperkinetic children. Arch Gen Psychiatry 33:1217-1231
77. Golden G (1977), The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol 2:69-70
78. Golden G (1982), Stimulant medication in Tourette's syndrome (letter). JAMA 248:1063
79. Goodman R (1989), Genetic factors in hyperactivity account for about half of the explainable variance. Br Med J 298:1407-1408
80. Goodman R, Stevenson J (1989a), A twin study of hyperactivity: I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires. J Child Psychol Psychiatry 30:671-689
81. Goodman R, Stevenson J (1989b), A twin study of hyperactivity: II. The aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry 30:691-709
82. Greenberg L, Yellin A, Spring C, Metcalf M (1975), Clinical effects of imipramine and methylphenidate in hyperactive children. Int J Ment Health 4:144-156
83. Greenhill LL, Rieder RO, Wender PH, Buchsbaum M, Zhan TP (1973), Lithium carbonate in the treatment of hyperactive children. Arch Gen Psychiatry 28:636-640
84. Gross M (1973), Imipramine in the treatment of minimal brain dysfunction in children. Psychosomatics 14:283-285
85. Gross M (1976), Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. J Pediatr 58:423-431
86. Gross MD (1975), Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome. Psychosomatics 16:26-27
87. Gualtieri CT, Evans RW (1988), Motor performance in hyperactive children treated with imipramine. Percept Mot Skills 66:763-769
88. Gualtieri CT, Ondrusek MG, Finley C (1985), Attention deficit disorders in adults. Clin Neuropharmacol 8:343-356
89. Gunning B (1992), A controlled trial of clonidine in hyperkinetic children. Thesis, Department of Child and Adolescent Psychiatry, Academic Hospital Rotterdam, Sophia Children's Hospital Rotterdam, the Netherlands
90. Harvey DHP, Marsh RW (1978), The effects of decaffeinated coffee versus whole coffee on hyperactive children. Dev Med Child Neurol 20:81-86
91. Hechtman L (1992), Long-term outcome in attention-deficit hyperactivity disorder. Psychiatr Clin North Am 1:553-565
92. Hinshaw S, Buhrmester D, Heller T (1989), Anger control in response to verbal provocation: effects of stimulant medication for boys with ADHD. J Abnorm Child Psychol 17:393-407
93. Hinshaw SP, Heller T, McHale JP (1992), Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate. J Consult Clin Psychol 60:274-281
94. Hoge SK, Biederman J (1986), A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. J Clin Psychiatry 47:478-479
95. Huessy H, Wright A (1970), The use of imipramine in children's behavior disorders. Acta Paedopsychiatr 37:194-199
96. Hunt RD (1987), Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADDH. Psychopharmacol Bull 23:111-114
97. Hunt RD, Arnsten AFT, Asbell MD (1995), An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50-54
98. Hunt RD, Minderaa RB, Cohen DJ (1985), Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 617-629
99. Jaffe S (1991), Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 30:773-775
100. Jankovic J (1993), Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol 50:286-288
101. Johnston C, Pelham WE, Hoza J, Sturges J (1988), Psychostimulant rebound in attention deficit disordered boys. J Am Acad Child Adolesc Psychiatry 27:806-810
102. Kaplan SL, Busner J, Kupietz S, Wasserman E, Segal B (1990), Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report. J Am Acad Child Adolesc Psychiatry 29:719-723
103. Klein RG (1987), Pharmacotherapy of childhood hyperactivity: an update. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven Press, pp 1215-1225
104. Klorman R, Brumaghim J, Fitzpatrick P, Borgstedt A, Strauss J (1994), Clinical and cognitive effects of methylphenidate on children with attention deficit disorder as a function of aggression/oppositionality and age. J Abnorm Psychol 103:206-221
105. Klorman R, Brumaghim JT, Salzman LF et al. (1988), Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. J Abnorm Psychol 97:413-422
106. Klorman R, Brumaghim JT, Salzman LF et al. (1989), Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. Psychopharmacol Bull 25:109-113
107. Klorman R, Coons HW, Borgstedt AD (1987), Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: I. Clinical findings. J Am Acad Child Adolesc Psychiatry 26:363-367
108. Konkol R, Fischer M, Newby R (1990), Double-blind, placebo-controlled stimulant trial in children with Tourette's syndrome and ADHD (abstract). Ann Neurol 28:424
109. Krakowski AJ (1965), Amitriptyline in treatment of hyperkinetic children: a double-blind study. Psychosomatics 6:355-360
110. Kupietz SS, Balka EB (1976), Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy. Psychopharmacology 50:29-33
111. Kupietz SS, Winsberg BG, Richardson E, Maitinsky S, Mendell N (1988), Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects. J Am Acad Child Adolesc Psychiatry 27:70-77
112. Lerer RJ, Lerer MP (1977), Responses of adolescents with minimal brain dysfunction to methylphenidate. J Learn Disabil 10:223-228
113. Livingston R, Dykman R, Ackerman P (1992), Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder. J Child Adolesc Psychopharmacol 2:115-122
114. Lowe TL, Cohen DJ, Detlor J (1982), Stimulant medications precipitate Tourette's syndrome. JAMA 247:1168-1169
115. MacKay MC, Beck L, Taylor R (1973), Methylphenidate for adolescents with minimal brain dysfunction. N Y State J Med 73:550-554
116. Mannuzza S, Gittelman-Klein R, Bonagura N, Malloy P, Giampino TL, Addalli KA (1991), Hyperactive boys almost grown up: V. Replication of psychiatric status. Arch Gen Psychiatry 48:77-83
117. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M (1993), Adult outcome of hyperactive boys: educational achievement, occupational rank and psychiatric status. Arch Gen Psychiatry 50:565-576
118. Manshadi M, Lippmann S, ODaniel RG, Blackman A (1983), Alcohol abuse and attention deficit disorder. J Clin Psychiatry 44:379-380
119. Mattes JA (1986), Propranolol for adults with temper outbursts and residual attention deficit disorder. J Clin Psychopharmacol 6:299-302
120. Mattes JA, Boswell L, Oliver H (1984), Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41:1059-1063
121. Mattes JA, Gittelman R (1983), Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 40:317-521
122. Mayes S, Crites D, Bixler E, Humphrey F, Mattison R (1994), Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status. Dev Med Clin Neurol 36:1099-1107
123. Medical Letter (1990), 32:37-40
124. Milberger S, Biederman J, Sprich-Buckminster S, Faraone S, Krifcher-Lehman B (1993), Are perinatal complications relevant to the manifestation of attention-deficit hyperactivity disorder? In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Antonio, TX
125. Murphy D, Pelham W, Lang A (1992), Aggression in boys with ADHD: methylphenidate effects on naturalistically observed aggression, response to provocation, and social information processing. J Abnorm Child Psychol 20:451-466
126. Pataki C, Carlson G, Kelly K, Rapport M, Biancaniello T (1993), Side effects of methylphenidate and desipramine alone and in combination in children. Am J Psychiatry 32:1065-1072
127. Pelham W, Greenslade K, Vodde-Hamilton M et al. (1990), Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison ot standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 86:226-237
128. Pelham WE, Bender ME, Caddell J, Booth S, Moorer SH (1985), Methylphenidate and children with attention deficit disorder. Arch Gen Psychiatry 42:948-952
129. Pelham WE, Walker JL, Sturges J, Hoza J (1989), Comparative effects of methylphenidate on ADD girls and boys. J Am Acad Child Adolesc Psychiatry 28:773-776
130. Pliszka SR (1989), Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882-887
131. Preskorn SH, Weller EB, Weller RA, Glotzbach E (1983), Plasma levels of imipramine and adverse effects in children. Am J Psychiatry 140:1332-1335
132. Price AR, Leckman JF, Pauls DL, Cohen DJ, Kidd KK (1986), Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins. Neurology 36:232-237
133. Prince J, Wilens T, Spencer T, Wozniak J, Biederman J (1994). Clonidine for ADHD related sleep disturbances. In: Scientific Proceedings of the 41st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York
134. Quinn PO, Rapoport JL (1975), One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry 132:241-245
135. Rapoport J, Mikkelsen E (1978), Antidepressants. In: Pediatric Psychopharmacology, Werry J, ed. New York: Brunner/Mazel, pp 208-233
136. Rapoport JL, Quinn P, Bradbard G, Riddle D, Brooks E (1974), Imipramine and methylphenidate treatment of hyperactive boys: a double-blind comparison. Arch Gen Psychiatry 30:789-793
137. Rapport MD, Carlson GA, Kelly KL, Pataki C (1993), Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. J Am Acad Child Adolesc Psychiatry 32:333-342
138. Rapport MD, DuPaul GJ (1986), Hyperactivity and methylphenidate: rate-dependent effects on attention. Int Clin Psychopharmacol 1:45-52
139. Rapport MD, DuPaul GJ, Kelly KL (1989a), Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharmacol Bull 25:285-290
140. Rapport MD, Jones JT, DuPaul GJ et al. (1987), Attention deficit disorder and methylphenidate: group and single-subject analyses of dose effects on attention in clinic and classroom settings. J Clin Child Psychol 16:329-338
141. Rapport MD, Quinn SO, DuPaul GJ, Quinn LP, Kelly KL (1989b), Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance. J Abnorm Child Psychol 17:669-689
142. Rapport MD, Stoner G, DuPaul GJ, Kelly KL, Tucker SB, Shroeler T (1988), Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings. J Am Acad Child Adolesc Psychiatry 27:60-69
143. Ratey J, Greenberg M, Lindem K (1991), Combination of treatments for attention deficit disorders in adults. J Nerv Ment Dis 176:699-701
144. Reimherr F, Hedges D, Strong R, Wender P (1995), An open-trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Presented at the New Clinical Drug Evaluation Unit Program, Orlando, FL
145. Reimherr FW, Wender PH, Wood DR, Ward M (1987), An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. Am J Psychiatry 144:1071-1073
146. Riddle MA, Hardin MT, Cho SC, Woolston JL, Leckman JF (1988), Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 27:811-814
147. Safer DJ, Allen RP (1975), Stimulant drug treatment of hyperactive adolescents. Dis Nerv Syst 36:454-457
148. Safer DJ, Allen RP, Barr E (1972), Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 287:217-220
149. Satterfield JH, Cantwell DP, Schell A, Blaschke T (1979), Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry 36:212-217
150. Schachar R, Hoppe C, Schell A (1987), Changes in family function and relationships in children who respond to methylphenidate. J Am Acad Child Adolesc Psychiatry 26:728-732
151. Schleifer N, Weiss G, Cohen N, Elman M, Cvejic H, Kruger E (1975), Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry 45:38-50
152. Schnackenberg RC (1973), Caffeine as a substitute for schedule II stimulants in hyperkinetic children. Am J Psychiatry 130:796-798
153. Shapiro AK, Shapiro E (1981), Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Compr Psychiatry 22:265-273
154. Simeon JG, Ferguson HB, Van Wyck Fleet J (1986), Bupropion effects in attention deficit and conduct disorders. Can J Psychiatry 31:581-585
155. Singer S, Brown J, Quaskey S, Rosenberg L, Mellits E, Denckla M (1994), The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 95:74-81
156. Solanto MV, Wender EH (1989). Does methylphenidate constrict cognitive functioning? J Am Acad Child Adolesc Psychiatry 28:897-902
157. Spencer T, Biederman J, Kerman K, Steingard R, Wilens T (1993a), Desipramine in the treatment of children with tic disorder or Tourette's syndrome and attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 32:354-360
158. Spencer T, Biederman J, Wilens T, Steingard R, Geist D (1993b), Nortripryline in the treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 32:205-210
159. Spencer T, Wilens TE, Biederman J, Faraone SV, Ablon S, Lapey K (1995), A double blind comparison of methylphenidate and placebo in adults wich attention deficit hyperactivity disorder. Arch Gen Psychiatry 52:434-443
160. Spencer TJ, Biederman J, Steingard R, Wilens T (1993c), Bupropion exacerbates tics in children with attention deficit hyperactivity disorder and Tourette's disorder. J Am Acad Child Adolesc Psychiatry 32:211-214
161. Sprague RL, Barnes KR, Werry JS (1970), Methylphenidate and thioridazine: learning, reaction time, activity, and classroom behavior in disturbed children. Am J Orthopsychiatry 40:615-628
162. Sprague RL, Sleator EK (1977), Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science 198:1274-1276
163. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A (1993), Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 32:350-353
164. Strayhorn J, Rapp N, Donina W, Strain P (1988), Randomized trial of methylphenidate for an autistic child. J Am Acad Child Adolesc Psychiatry 27:244-247
165. Sverd J, Gadow K, Nolan E, Sprafkin J, Ezor S (1992), Methylphenidate in hyperactive boys with comorbid tic disorder: I. Clinical evaluations. Adv Neurol 58:271-282
166. Sverd J, Gadow KD, Paolicelli LM (1989), Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 28:574-579
167. Swanson J, Kinsbourne M, Roberts W, Zucker K (1978), Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61:21-24
168. Swanson JM, Granger D, Kliewer W (1987), Natural social behaviors in hyperactive children: dose effects of methylphenidate. J Consult Clin Psychol 55:187-193
169. Tannock R, Ickowicz A, Schachar R (1995), Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886-896
170. Tannock R, Schachar RJ, Carr RP, Logan GD (1989), Dose-response effects of on academic performance and overt behavior in hyperactive children. Pediatrics 84:648-657
171. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M (1987), Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 17:121-143
172. Trott GE, Friese HJ, Menzel M, Nissen G (1991), Use of moclobemide in children with attention deficit hyperacrivity disorder (Wirksamkeit und verrraglichkeit des selektiven MAO-A-Inhibitors moclobemid bei kindern mit hyperkinetischem syndrom) (both English and German versions). Jugendpsychiat 19:248-253
173. Varley CK (1983), Effects of methylphenidate in adolescents with attention deficit disorder. J Am Acad Child Psychiatry 22:351-354
174. Voelker SL, Lachar D, Gdowski LL (1983), The personality inventory for children and response to methylphenidate: preliminary evidence for predictive validity. J Pediatr Psychol 8:161-169
175. Watter N, Dreyfuss FE (1973), Modifications of hyperkinetic behavior by nortriptyline. Va Med Monthly 100:123-126
176. Weintraub S, Mesulam MM, Kramer L (1981), Disturbances in prosody. Acta Neurol 38:742-744
177. Weiss G, Hechtman L, Milroy T, Perlman T (1985), Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 24:211-220
178. Weizman A, Weitz R, Szekely G, Tyano S, Belmaker R (1984), Combination of neuroleptic and stimulant treatment in ADHD. J Am Acad Child Psychiatry 23:295-298
179. Wender P, Reimherr F, Wood D, Ward M (1985a), A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547-552
180. Wender PH, Reimherr FW (1990), Bupropion treatment of attention-deficit
181. Wender PH, Reimherr FW, Wood D, Ward M (1985b), A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547-552
182. Wender PH, Reimherr FW, Wood DR (1981). Attention deficit disorder ("minimal brain dysfunction") in adults. A replication study of diagnosis and drug treatment. Arch Gen Psychiatry 38:449-456
183. Wender PH, Wood DR, Reimherr FW (1985c), Pharmacological treatment of attention deficit disorder, residual type (ADD, RT, "minimal brain dysfunction," "hyperactivity") in adults. Psychopharmacol Bull 21:222-230
184. Wender PH, Wood DR, Reimherr FW, Ward M (1983), An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res 9:329-36
185. Werry I (1980), Imipramine and methylphenidate in hyperactive children. J Child Psychol Psychiatry 21:27-35
186. Whalen C (1989), Does stimulant medication improve the peer status of hyperactive children? J Consult Clin Psychol 57:545-549
187. Whalen C, Henker B, Granger D (1990), Social judgement processes in hyperactive boys: effects of methylphenidate and comparisons with normal peers. J Abnorm Child Psychol 18:297-316
188. Whalen C, Henker B, Swanson J, Granger D, Kliewer W, Spencer J (1987), Natural social behaviors in hyperactive children: dose effects of methylphenidate. J Consult Clin Psychol 55:187-193
189. Wilens T, Prince J, Spencer T et al. (1994), Double-blind comparison of desipramine and placebo in adults with attention deficit hyperactivity disorder: preliminary results. In: Scientific Proceedings of the 41st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York
190. Wilens T, Spencer T, Biederman J, Wozniak J, Connor D (1995a), Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 34:110-112
191. Wilens TE, Biederman J (1992), The stimulants. Psychiatr Clin North Am 15:191-222
192. Wilens TE, Biederman J, Geist DE, Steingard R, Spencer T (1993), Nortriptyline in the treatment of attention deficit hyperactivity disorder: a chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 32:343-349
193. Wilens TE, Biederman JB, Mick E, Spencer T (1995b), A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 183:48-50
194. Winsberg BG, Bialer I, Kupietz S, Tobias J (1972), Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children. Am J Psychiatry 128:1425-1431
195. Winsberg BG, Goldstein S, Yepes EE (1975), Imipramine and electrocardiographic abnormalities in hyperactive children. Am J Psychiatry 132:542-547
196. Winsberg BG, Press M, Bialer I, Kupietz S (1974), Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children. Pediatrics 53:236-241
197. Wood D, Reimherr F, Wender P (1982), The use of l-deprenyl in the treatment of attention deficit disorder, residual type. Presented at the American College of Neuropsychopharmacology, San Juan, PR
198. Wood DR, Reimherr FW, Wender PH, Johnson GE (1976), Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry 33:1453-1460
199. Wozniak J, Biederman J, Kiely K et al. (1995), Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 34:867-876
200. Yepes LE, Balka EB, Winsberg BG, Bialer I (1977), Amitripryline and methylphenidate treatment of behaviorally disordered children. J Child Psychol Psychiatry 18:39-52
201. Zametkin A, Rapoport JE, Murphy DL, Linnoila M, Ismond D (1985), Treatment of hyperactive children with monoamine oxidase inhibitors: I. Clinical efficacy. Arch Gen Psychiatry 42:962-966
202. Zametkin AJ, Rapoport JL (1987), Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26:676-686